Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched their Fingolimod Capsules, 0.5 mg, the generic version of Gilenya®1 Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation.
Commenting on the launch, Sanjeev Krishan, President, Glenmark North America said, “We are very pleased to bring to market a lower cost alternative to Gilenya® Capsules, 0.5 mg. This launch confirms our commitment to provide quality and affordable pharmaceutical products to patients.”
- Read more about Glenmark Pharmaceuticals launches Fingolimod Capsules in the US
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/glenmark-pharmaceuticals-launches-fingolimod-capsules-in-the-us
No comments:
Post a Comment